NO154268C - Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive 6alfa-flour-9a-klor-prednisolon-17,21-diestere. - Google Patents

Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive 6alfa-flour-9a-klor-prednisolon-17,21-diestere.

Info

Publication number
NO154268C
NO154268C NO803451A NO803451A NO154268C NO 154268 C NO154268 C NO 154268C NO 803451 A NO803451 A NO 803451A NO 803451 A NO803451 A NO 803451A NO 154268 C NO154268 C NO 154268C
Authority
NO
Norway
Prior art keywords
6alfa
prednisolon
diesters
flour
chlorine
Prior art date
Application number
NO803451A
Other languages
English (en)
Norwegian (no)
Other versions
NO154268B (no
NO803451L (no
Inventor
Peter Macdonald
Original Assignee
Sterosynt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT7927353A external-priority patent/IT1209140B/it
Priority claimed from IT49853/80A external-priority patent/IT1143039B/it
Application filed by Sterosynt Ltd filed Critical Sterosynt Ltd
Publication of NO803451L publication Critical patent/NO803451L/no
Publication of NO154268B publication Critical patent/NO154268B/no
Publication of NO154268C publication Critical patent/NO154268C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO803451A 1979-11-16 1980-11-14 Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive 6alfa-flour-9a-klor-prednisolon-17,21-diestere. NO154268C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT7927353A IT1209140B (it) 1979-11-16 1979-11-16 6 alfa-fluoro-prednisolone 17,21-diesteri.
IT49853/80A IT1143039B (it) 1980-10-09 1980-10-09 6-alfa-fluoro-prednisolone 17,21-diesteri

Publications (3)

Publication Number Publication Date
NO803451L NO803451L (no) 1981-05-18
NO154268B NO154268B (no) 1986-05-12
NO154268C true NO154268C (no) 1986-08-20

Family

ID=26328728

Family Applications (3)

Application Number Title Priority Date Filing Date
NO803450A NO803450L (no) 1979-11-16 1980-11-14 Nye 6alfa-fluor-prednisolon-17,21-diestere og fremgangsmaate ved fremstilling derav
NO803452A NO803452L (no) 1979-11-16 1980-11-14 Nye 6alfa,9alfa-difluor-16-metyl-prednisolon-17,21-diestere og fremgangsmaate ved fremstilling derav
NO803451A NO154268C (no) 1979-11-16 1980-11-14 Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive 6alfa-flour-9a-klor-prednisolon-17,21-diestere.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
NO803450A NO803450L (no) 1979-11-16 1980-11-14 Nye 6alfa-fluor-prednisolon-17,21-diestere og fremgangsmaate ved fremstilling derav
NO803452A NO803452L (no) 1979-11-16 1980-11-14 Nye 6alfa,9alfa-difluor-16-metyl-prednisolon-17,21-diestere og fremgangsmaate ved fremstilling derav

Country Status (12)

Country Link
US (2) US4358445A (de)
EP (3) EP0029151B1 (de)
AU (3) AU531292B2 (de)
CA (3) CA1162921A (de)
DE (3) DE3069074D1 (de)
DK (3) DK487480A (de)
ES (3) ES8200121A1 (de)
FI (3) FI69474C (de)
IE (1) IE50829B1 (de)
NO (3) NO803450L (de)
PH (2) PH17696A (de)
YU (3) YU291380A (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0095894A3 (de) * 1982-05-31 1985-01-02 Ohta Seiyaku Kabushiki Kaisha. 6-Alpha Methyl Prednisolon Derivate
PT78973A (en) * 1984-07-25 1984-08-01 Joao Emerico Villax New preparation process of the 9alpha-fluoro 17,21-acylates or hidroxilades in 17 and 21 chloro-corticosteroid
US5110809A (en) * 1988-03-21 1992-05-05 Bristol-Myers Squibb Company Antifungal gel formulations
US20060165606A1 (en) * 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
CA2473471A1 (en) 2001-11-29 2003-06-12 Taro Pharmaceuticals U.S.A., Inc. Method for the preparation of 6-alpha-fluoro corticosteroids
CN101759760B (zh) * 2008-11-28 2013-02-13 天津金耀集团有限公司 一种含氟甾体激素的制备
CN101928318A (zh) * 2009-06-24 2010-12-29 天津金耀集团有限公司 一种含氟甾体激素的制备
WO2011151941A1 (ja) 2010-06-04 2011-12-08 国立大学法人東京大学 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
CN108676774B (zh) 2011-12-01 2023-05-09 国立大学法人东京大学 诱导调节性t细胞的增殖或积累的人源细菌
WO2015006355A2 (en) * 2013-07-09 2015-01-15 Puretech Ventures, Llc Compositions containing combinations of bioactive molecules derived from microbiota for treatment of disease
CN108727458A (zh) * 2018-05-10 2018-11-02 浙江仙居仙乐药业有限公司 一种17-丙酸酯的合成方法
CN112851734B (zh) * 2019-11-27 2024-02-06 重庆华邦胜凯制药有限公司 一种二丙酸倍他米松的制备方法
CN111944002A (zh) * 2020-07-29 2020-11-17 河南利华制药有限公司 一种倍氯米松二丙酸酯中间体及制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB924931A (de) * 1958-07-09
US3499016A (en) * 1958-08-04 1970-03-03 Upjohn Co 6alpha-fluoro-16alpha-methyl derivatives of the pregnane series
GB933859A (de) * 1958-09-06 1963-08-14 Syntex S.A.
US3007923A (en) * 1959-01-22 1961-11-07 Lab Francais Chimiotherapie Process for the fluorination of 9beta, 11beta-epoxy and 5alpha, 6alpha-epoxy steroids
DE1081153B (de) * 1959-01-23 1960-05-05 Telefunken Gmbh Verfahren zur Bepastung der Emissionsschichttraeger von Flachkathoden mit Emissionsmaterial und Vorrichtung zur Durchfuehrung des Verfahrens
US3714353A (en) * 1959-08-11 1973-01-30 Upjohn Co THERAPEUTIC COMPOSITIONS COMPRISING A 6 alpha ; 9 alpha -DIFLUORO-11 beta ,17 alpha ,21-TRIHYDROXY-16 alpha -METHYL-1,4-PREGNADIENE-3,20-DIONE AND 21-ACYLATES
US3626063A (en) * 1959-08-11 1971-12-07 Upjohn Co Therapeutic compositions comprising 6-fluoro-16-methyl prednisolone, the 21 acylates and salts thereof
DE1195748B (de) * 1961-06-24 1965-07-01 Vismara Francesco Spa Verfahren zur Herstellung von 1'-substituierten 17alpha, 21-(1'-Alkoxy)-methylendioxysterioden
GB1047518A (en) * 1963-06-11 1966-11-02 Glaxo Lab Ltd 17ª‡-monoesters of 11,17,21-trihydroxy steroid compounds
US3463852A (en) * 1966-01-14 1969-08-26 Schering Corp Treating allergies with steroids of the pregnane series
US3422193A (en) * 1966-08-11 1969-01-14 Schering Corp 17-mono esters of corticoids
IT1061787B (it) * 1967-03-01 1983-04-30 Vismara Francesco Spa Miglioramenti relativi alla preparazione di 17 benzoato di betametazone
US3780177A (en) * 1967-06-16 1973-12-18 Warner Lambert Co 17-butyrate,21-ester derivatives of 6alpha,9alpha-difluoroprednisolone,compositions and use
SE339685B (de) * 1967-06-16 1971-10-18 Warner Lambert Pharmaceutical
US3784692A (en) * 1967-06-16 1974-01-08 Warner Lambert Co 17-propionate,21-ester derivatives of 6alpha,9alpha-difluoroprednisolone,compositions and use
IT1034011B (it) * 1969-06-26 1979-09-10 Vister Vismara Terapeutici S P Processo per la prapratzione di 17 monoesteri di 17 a 21 diossisteroidi per idrolisi die corpispondenti 17 21 ortoesteri ciclici a ph control lato
DE2011559B2 (de) * 1970-03-07 1973-03-08 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur herstellung von 9alpha-chlor-11beta-hydroxysteroiden
US3691214A (en) * 1970-06-08 1972-09-12 Warner Lambert Pharmaceutical 17-valerate ester of 6alpha,9alpha-difluoroprednisolone,its compositions and use as an anti-inflammatory agent
US3857941A (en) * 1970-06-22 1974-12-31 Warner Lambert Co Pharmaceutical compositions and use of prednisolone 17-benzoate
DE2144405A1 (de) * 1971-09-04 1973-03-08 Merck Patent Gmbh Verfahren zur herstellung von estern der pregnanreihe
DE2365992C3 (de) 1972-03-09 1982-05-19 The Upjohn Co., 49001 Kalamazoo, Mich. 6α-Fluor-17,21-dihydroxy-16β-methylpregna-4,9(11)-dien-3,20-dion-17,21-diacetat und Verfahren zu dessen Herstellung
US3980778A (en) * 1973-10-25 1976-09-14 The Upjohn Company Anti-inflammatory steroid
SE418294B (sv) * 1974-03-27 1981-05-18 Plurichemie Anstalt Sett att framstella en 16alfa- eller 16beta-9alfa-klor eller -fluorsteroidester
US4018918A (en) * 1975-05-20 1977-04-19 The Upjohn Company Topical clindamycin preparations
CH611631A5 (en) * 1975-07-23 1979-06-15 Ciba Geigy Ag Process for the preparation of 11,12-unsaturated 9alpha-fluorosteroids
US4036831A (en) * 1975-10-28 1977-07-19 Steroid Development Company Establishment Trimethyl siloxane steroid intermediates
LU75809A1 (de) 1976-09-16 1978-05-12
US4261984A (en) * 1978-04-05 1981-04-14 Syntex (U.S.A.) Inc. 17β-thiocarboxylic acid esters of 3-oxo-4-halo-16β-methylandrost-4-enes
NL187577C (nl) * 1978-04-05 1991-11-18 Sibla Srl 3-acetoxy-9beta,11beta-epoxy-pregna-1,3,5-trienen, werkwijze voor de bereiding daarvan en werkwijze voor de bereiding van 6alfa-halogeen-pregna-1,4-dieen-3-onen.

Also Published As

Publication number Publication date
EP0030615A1 (de) 1981-06-24
ES496841A0 (es) 1981-10-16
EP0030615B1 (de) 1984-08-29
AU6439080A (en) 1981-05-21
EP0029151A3 (en) 1981-08-26
ES496839A0 (es) 1981-10-16
AU531292B2 (en) 1983-08-18
DK487580A (da) 1981-05-17
DE3071122D1 (en) 1985-10-31
ES8200120A1 (es) 1981-10-16
ES496840A0 (es) 1981-10-16
EP0029924A1 (de) 1981-06-10
ES8200122A1 (es) 1981-10-16
YU291280A (en) 1983-02-28
DK487680A (da) 1981-05-17
EP0029151A2 (de) 1981-05-27
FI69474C (fi) 1986-02-10
AU6438980A (en) 1981-05-21
US4358445A (en) 1982-11-09
AU6438880A (en) 1981-05-21
YU291180A (en) 1983-02-28
PH19406A (en) 1986-04-10
CA1162921A (en) 1984-02-28
FI803579L (fi) 1981-05-17
CA1162532A (en) 1984-02-21
ES8200121A1 (es) 1981-10-16
US4576936A (en) 1986-03-18
FI803577L (fi) 1981-05-17
DK487480A (da) 1981-05-17
NO154268B (no) 1986-05-12
NO803451L (no) 1981-05-18
DE3069074D1 (en) 1984-10-04
DE3068965D1 (en) 1984-09-20
YU41747B (en) 1987-12-31
IE50829B1 (en) 1986-07-23
YU291380A (en) 1983-02-28
EP0029924B1 (de) 1984-08-15
FI803578L (fi) 1981-05-17
IE802379L (en) 1981-05-16
CA1162533A (en) 1984-02-21
AU530802B2 (en) 1983-07-28
NO803452L (no) 1981-05-18
NO803450L (no) 1981-05-18
FI69474B (fi) 1985-10-31
EP0029151B1 (de) 1985-09-25
AU530348B2 (en) 1983-07-14
PH17696A (en) 1984-11-08

Similar Documents

Publication Publication Date Title
NO154964C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive piperidinderivater.
NO154521C (no) Analogifremgangsmaate for fremstilling av nye, terapeutisk aktive piperidinderivater.
NO155774C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazo-diazepin-derivater.
NO154918C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
NO153136C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive naftyridinderivater.
NO148643C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nye 1-(1,3-dixolan-2-ylmetyl)-1h-imidazoler og-1h-1,2,4-triazoler
NO151085C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive peptidylargininaldehydderivater
NO155055C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-carbolin-3-carboxylsyrederivater.
NO150760C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotiazoler.
NO152841C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive nye 4-aroylimidazol-2-oner.
NO154883C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive 2-acylaminomethyl-1,4-benzodiazepiner.
NO810675L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO156787C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO160444C (no) Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive imidazo-pyrazolo-pyrimidiner.
NO154268C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive 6alfa-flour-9a-klor-prednisolon-17,21-diestere.
NO823520L (no) Fremgangsmaate ved fremstilling av nye, terapeutisk aktive carbohydrater.
NO800857L (no) Fremgangsmaate for fremstilling av nye antisekretorisk aktive forbindelser.
NO156011C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive 3, 6, 7, 8-substituerte-s-triazolo (4,3-b) pyridaziner.
NO154920C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive, nye pyridothienotriaziner.
NO160370C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive penam-1,1-dioksyd-forbindelser.
NO154396C (no) Analogifremgangsmaate ved fremstilling av nye, terapeutisk aktive halovincamonderivater.
NO158800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indenderivater.
NO156167C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinon-derivater.
NO154795C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme 1,2,4-oxadiazolin-5-on-derivater.
NO164095C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive estere av 3-(3-substituerte-amino-2-hydroksypropoksy)-4-substituerte-1,2,5-tiadiazolderivater.